5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)pyridin-2-amine, 95.0%, 25g

2,6,8-trimethyl-4-quinolinamine, 95.0%, 5g

(R)-1-Amino-indan-4-ol hydrochloride, 96%, 100mg

2-(Trifluoromethyl)pyrimidin-5-ol, 97.0%, 10g

3-(Morpholine-4-carbonyl)phenylboronic acid, 95.0%, 250mg

4-(Pyridin-3-yloxy)-phenylamine, 95.0%, 1g

5-Benzylthiazolidine-2,4-dione, 97%, 1g

(S)-[4-(Pyridin-4-yl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-2,6-diyl]bis[bis[4-(tert-butyl)phenyl]methanol]>85.0%(HPLC)50mg

3-Ethyl-4-(tetrahydro-thiopyran-4-yl)-pyridine, 1g

(R)-METHYL 1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLATE HCL, 95.0%, 25g

2,3,6-TRIFLUORO-5-NITROBENZOIC ACID, 95.0%, 1g

Laborglasflaschen GL 45 DURAN®, 250 ml, mit Hochtemp.-Verschlüssen, 10 Stück

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxamide, 98%, 250mg